Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
19:48
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2012 World Congress

 

8-12 July, 2012 Paris, FRANCE
Sponsored by:

FAQs
   
Discussion forum - WFH 2012 World Congress
    Topic - Inhibitors Pathogenesis, Prevention and Treatment

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 134
Visits: 533
Title: F8 genotype and not polymorphisms in IL10, TNFA and CTLA4 influences inhibitor development in Argentine patients with severe HA.
Authors: Liliana Rossetti , Claudia Radic, Johanna Zuccoli, Irupé Szurkalo, Martín Abelleyro, Lilian Franzi, Laura Primiani, Miguel Candela, Raúl Pérez Bianco, Miguel de Tezanos Pinto, Irene Larripa, Carlos De Brasi.
Centre: IMEX (CONICET-ANM). IHEMA (Academia Nacional de Medicina). Fundación de la Hemofilia.

You must be registered to reply or comment.

F8 GENOTYPE AND NOT POLYMORPHISMS IN IL10, TNFA AND CTLA4 INFLUENCES INHIBITOR DEVELOPMENT IN ARGENTINE PATIENTS WITH SEVERE HA.

Liliana Rossetti
Thread initiator
Subspeciality
Reg: 6/25/2012 5:15:00 PM

Comment# 1

Development of FVIII inhibitors (INH) is a severe treatment complication that affects 20 of patients with severe haemophilia A (HA). Both genetic and environmental factors have been implicated in inhibitor formation. The objective was to characterize genetic factors associated with inhibitors in Argentine patients with severe HA.We characterized the HA-causative mutation in 170 patients classified by INH status by application of a laboratory algorithm including inverse shifting-PCR for F8 inversions, 37 PCR-amplifications for gross deletion detection, and for small-mutation screening by CSGE, and DNA-sequencing. To explore other genetic factors, we studied DNA polymorphisms in the genes encoding for interleukin-10 (IL10) (-1082:A/G), tumour necrosis factor-alpha (TNFA) (-308:G/A), and cytotoxic T-lymphocyte antigen-4 (CTLA4) (-318:C/T) that have been implicated as inhibitor risk factors in other populations.An unbiased series of 119 Argentine patients with severe HA with an absolut

Comment added on 6/25/2012 5:15:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 243
Visits: 2712
Title: Use of the Exergaming (Nintendo Wii) in the Rehabilitation of Patients withHemophilia.
Authors: JANAINA BOSSO JOSÉ DA SILVA , Rafael Fagnani, Egritti de Oliveira Zacarias da Silva,Marcia Aparecida Picoloto Matta, Margareth Castro Ozelo
Centre: UNICAMP

Poster most viewed in this topic
Poster: 133
Visits: 881
Title: A Canadian survey on the incidence and risk factors for inhibitor development insevere hemophilia A PUPs: 2005-2010.
Authors: Georges-Etienne Rivard , M. Carcao, C. Infante-Rivard, A.M. StainE. Paradis, J. Teitel
Centre: CHU Sainte-Justine, Montréal, QC, Canada


 
Sponsored by:















PosterSessionOnline
Logo Draft
 
Logo Cert